Part 4: Systems of Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

Reviewer Disclosures

Appendix 2. Reviewer Disclosures
Reviewer Employment Research Grant Other Research Support Speakers' Bureau/
Honoraria
Expert Witness Ownership Interest Consultant/
Advisory Board
Other

Joseph Grover

The University of North Carolina at Chapel Hill

None

None

None

None

None

None

None

Lia Lowrie

St. Louis University School of Medicine

None

None

None

None

None

None

None

Christian Martin-Gill

University of Pittsburgh Medical Center

None

None

None

None

None

None

None

Michael R. Sayre

University of Washington

NIH (Collaborator)†

None

None

City of Bellevue, WA*

None

Stryker Emergency Care†

None

Scott T. Youngquist

University of Utah

NINDS (PediDOSE Trial EMS Investigator)*; DoD (PAIN Clinical Trial Site PI)*; NHLBI (ICECAP Trial Site Investigator)*; AHRQ (FEED-PT Trial Site Investigator)*

None

None

None

None

Emergency Scientific*

None

This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.
†Significant.